Loading clinical trials...
Loading clinical trials...
A Phase I Trial for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Conditions
Interventions
DFMO
Etoposide
Locations
7
United States
Children's Hospital of Orange County
Orange, California, United States
Connecticut Children's Hospital
Hartford, Connecticut, United States
Arnold Palmer Hospital for Children- MD Anderson
Orlando, Florida, United States
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States
Levine Children's Hospital
Charlotte, North Carolina, United States
Start Date
February 1, 2010
Primary Completion Date
October 1, 2014
Completion Date
May 1, 2015
Last Updated
August 6, 2024
NCT04936529
NCT06541262
NCT04851119
NCT03363373
NCT05890781
NCT03050268
Lead Sponsor
Giselle Sholler
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions